封面
市场调查报告书
商品编码
1682022

2025年全球心臟AI监测与诊断市场报告

Cardiac AI Monitoring And Diagnostics Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年心臟人工智慧监测和诊断市场规模将呈指数级增长。到 2029 年,这一数字将成长至 55.4 亿美元,复合年增长率为 26.6%。预测期内的成长可归因于穿戴式装置和物联网设备的兴起、远端医疗和远端监控的日益普及、巨量资料分析和预测模型的整合、对以患者为中心的护理和远端病人参与的重视以及医疗保健基础设施的发展。预测期内的主要趋势包括穿戴式装置和人工智慧的整合、个人化风险评估和治疗计划、心血管事件的预测分析、多模态资料来源的整合以及互通性和资料整合标准。

心血管疾病(CVD)盛行率的上升预计将推动心臟 AI 监测和诊断市场的成长。 CVD包括影响心臟和血管的各种疾病,包括脑心臟疾病和风湿性心臟疾病。心臟人工智慧监测和诊断将有助于心血管疾病的早期诊断、风险评估和个人化治疗,改善患者的治疗效果。例如,根据英国心血管研究慈善机构英国心臟基金会的资料,截至2024年9月,英国约有760万人患有心臟和循环系统疾病,其中约400万人为男性,360万人为女性。这些疾病约占英国所有死亡人数的 27%,每年死亡人数超过 17 万人,每天约有 480 人死亡,每三分钟就有一人死亡。因此,心血管疾病发生率的不断上升正在刺激心臟人工智慧监测和诊断市场的成长。

心臟人工智慧监测和诊断市场的主要企业正专注于开发技术主导的医疗设备,例如基于人工智慧的植入式心臟监测器,以加强其在市场上的地位。以人工智慧为基础的植入式心臟监测仪是心血管医疗保健领域的突破性创新,可以持续且准确地监测心臟功能。例如,2023年5月,总部位于德国的着名心血管生物医学研究和技术公司Biotronik宣布FDA核准其BIOMONITOR IV植入式心臟监测器(ICM)。 BIOMONITOR IV ICM 采用 BIOTRONIK 最先进的人工智慧 SmartECG 演算法,为心臟监测准确性树立了新标准。透过利用先进的演算法,SmartECG 技术显着减少了假阳性,同时保持了对真正心臟病发作的高检测率。检测准确性的提高使医疗保健专业人员能够快速且准确地做出诊断,从而优化患者照护和治疗结果。此外,BIOMONITOR IV ICM 可区分不同类型的心臟收缩,例如过早心室收缩 (PVC) 和过早心房收缩 (PAC),进一步增强诊断能力和临床效用。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景,包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 世界心臟AI监测与诊断PESTEL分析(政治、社会、科技、环境、法律、驱动因素、限制因素)
  • 最终用途产业分析
  • 全球心臟人工智慧监测与诊断市场:成长率分析
  • 全球心臟人工智慧监测与诊断市场表现:规模与成长,2019-2024
  • 全球心臟人工智慧监测与诊断市场预测:规模与成长,2024-2029 年,2034 年
  • 全球心臟人工智慧监测与诊断总目标市场(TAM)

第六章市场区隔

  • 全球心臟人工智慧监测与诊断市场:按类型、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 心臟诊断
  • 心臟监测
  • 全球心臟人工智慧监测和诊断市场:按产品、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 软体
  • 硬体
  • 全球心臟人工智慧监测与诊断市场:应用、绩效及预测(2019-2024 年、2024-2029 年及 2034 年)
  • 缺血性心臟疾病或冠状动脉疾病(CAD)
  • 心律不整
  • 缺血性中风
  • 其他用途
  • 全球心臟人工智慧监测与诊断市场:按最终用户、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断中心
  • 其他最终用户
  • 全球心臟人工智慧监测与诊断市场:心臟诊断细分市场、类型、绩效及预测(2019-2024 年、2024-2029 年及 2034 年)
  • 心电图分析
  • 心臟超音波图检查分析
  • 心臟影像
  • 生物标记分析
  • 全球心臟人工智慧监测与诊断市场、心臟监测细分市场、类型、绩效及预测(2019-2024 年、2024-2029 年及 2034 年)
  • 穿戴式心臟监测器
  • 远端患者监护系统
  • 植入式心臟装置
  • 连续心电图监测系统

第七章 区域和国家分析

  • 全球心臟人工智慧监测与诊断市场:按地区、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 全球心臟人工智慧监测和诊断市场:按国家/地区、绩效和预测,2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章:义大利市场

第20章:西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第30章竞争格局与公司概况

  • 心臟人工智慧监测与诊断市场:竞争格局
  • 心臟人工智慧监测和诊断市场:公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Boston Scientific Corporation
  • ZOLL Medical Corporation
  • Canon Medical Systems Corporation
  • Biotronik SE & Co. KG
  • iRhythm Technologies Inc.
  • Tempus Labs Inc.
  • Viz.ai Inc.
  • HeartFlow Inc.
  • Aidoc
  • Eko Devices Inc.
  • CardioFocus Inc.
  • Circle Cardiovascular Imaging Inc.
  • Ultromics Limited.
  • Cathworks
  • Medicalgorithmics SA

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年心臟 AI 监测与诊断市场:提供新机会的国家
  • 2029 年心臟 AI 监测与诊断市场:细分领域带来新机会
  • 2029年心臟AI监测与诊断市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r27627

Cardiac AI monitoring and diagnostics involve the application of artificial intelligence (AI) technologies in the field of cardiology to monitor and diagnose various cardiovascular conditions. This utilizes advanced algorithms and machine learning techniques to analyze data from cardiac monitoring devices, such as electrocardiograms (ECGs).

The main categories of cardiac AI monitoring and diagnostics are cardiac diagnostics and cardiac monitoring. Cardiac diagnostics encompass methods and procedures used to identify heart conditions associated with unhealthy or pathologic heart function. The products in this category include software and hardware used in applications such as ischemic heart diseases or coronary artery disease (CAD), cardiac arrhythmias, ischemic stroke, and others. End users of these cardiac AI solutions include hospitals, diagnostic centers, and various healthcare facilities.

The cardiac AI monitoring and diagnostics research report is one of a series of new reports from The Business Research Company that provides cardiac AI monitoring and diagnostics market statistics, including the cardiac AI monitoring and diagnostics industry's global market size, regional shares, competitors with an cardiac AI monitoring and diagnostics market share, detailed cardiac AI monitoring and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac AI monitoring and diagnostics industry. This cardiac AI monitoring and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiac ai monitoring and diagnostics market size has grown exponentially in recent years. It will grow from $1.71 billion in 2024 to $2.16 billion in 2025 at a compound annual growth rate (CAGR) of 26.4%. The growth in the historic period can be attributed to aging population demographics, rise in remote patient monitoring, increased healthcare expenditure, clinical research and validation studies, focus on preventive healthcare.

The cardiac ai monitoring and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $5.54 billion in 2029 at a compound annual growth rate (CAGR) of 26.6%. The growth in the forecast period can be attributed to expansion of wearable and IoT devices, increasing adoption of telemedicine and remote monitoring, integration of big data analytics and predictive modeling, focus on patient-centered care and remote patient engagement, healthcare infrastructure development. Major trends in the forecast period include integration of AI with wearable devices, personalized risk assessment and treatment planning, predictive analytics for cardiovascular events, integration of multimodal data sources, interoperability and data integration standards.

The rising prevalence of cardiovascular diseases (CVDs) is expected to drive growth in the cardiac AI monitoring and diagnostics market. CVDs encompass a range of conditions affecting the heart and blood vessels, including cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Cardiac AI monitoring and diagnostics facilitate early diagnosis, risk assessment, and personalized treatment for cardiovascular conditions, improving patient outcomes. For example, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with around 4 million men and 3.6 million women affected. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or about 480 deaths per day, equivalent to one death every three minutes. Consequently, the increasing incidence of cardiovascular diseases is fueling growth in the cardiac AI monitoring and diagnostics market.

Leading companies operating in the cardiac AI monitoring and diagnostics market are directing their efforts towards the development of technology-driven medical devices, such as artificial intelligence-based implantable cardiac monitors, to solidify their position in the market. Artificial intelligence-based implantable cardiac monitors represent a groundbreaking innovation in cardiovascular healthcare, offering continuous and accurate monitoring of cardiac function. For example, in May 2023, Biotronik, a renowned cardiovascular biomedical research and technology company based in Germany, announced the FDA approval of its BIOMONITOR IV implantable cardiac monitor (ICM). Equipped with BIOTRONIK's cutting-edge SmartECG algorithm powered by artificial intelligence, the BIOMONITOR IV ICM sets a new standard in cardiac monitoring accuracy. By leveraging advanced algorithms, the SmartECG technology significantly reduces false identifications while maintaining a high detection rate for genuine cardiac episodes. This enhancement in detection accuracy empowers healthcare professionals to make prompt and precise diagnoses, thus optimizing patient care and outcomes. Furthermore, the BIOMONITOR IV ICM distinguishes between different types of cardiac contractions, such as premature ventricular contractions (PVCs) and premature atrial contractions (PACs), further enhancing its diagnostic capabilities and clinical utility.

In January 2022, Koninklijke Philips N.V., a healthcare technology company headquartered in the Netherlands, completed the acquisition of Cardiologs Technologies SAS, a medical technology company based in France, for an undisclosed sum. This strategic move positions Cardiologs to enhance Philips' cardiac monitoring and diagnostics portfolio through the integration of innovative software solutions, electrocardiogram (ECG) analysis, and reporting services. Cardiologs Technologies SAS specializes in optimizing cardiac diagnostics through the utilization of artificial intelligence (AI) and cloud technologies, aligning with Philips' commitment to advancing healthcare through cutting-edge innovations.

Major companies operating in the cardiac ai monitoring and diagnostics market report are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.

North America was the largest region in the cardiac AI monitoring and diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac ai monitoring and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac AI monitoring and diagnostics market consists of revenues earned by entities by providing services such as ST-segment monitoring, arrhythmia detection, heart rate variability analysis, risk stratification, and echocardiogram interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac AI monitoring and diagnostics market also includes sales of echocardiography devices, cardiac MRI and CT analysis, electrocardiogram (ECG) analysis tools, and wearable devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac AI Monitoring And Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac ai monitoring and diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac ai monitoring and diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac ai monitoring and diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Cardiac Diagnostics; Cardiac Monitoring
  • 2) By Product: Software; Hardware
  • 3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD); Cardiac Arrhythmias; Ischemic Stroke; Other Applications
  • 4) By End Users: Hospitals; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Cardiac Diagnostics: ECG Analysis; Echocardiography Analysis; Cardiac Imaging; Biomarker Analysis
  • 2) By Cardiac Monitoring: Wearable Cardiac Monitors; Remote Patient Monitoring Systems; Implantable Cardiac Devices; Continuous ECG Monitoring Systems
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac AI Monitoring And Diagnostics Market Characteristics

3. Cardiac AI Monitoring And Diagnostics Market Trends And Strategies

4. Cardiac AI Monitoring And Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiac AI Monitoring And Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiac AI Monitoring And Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiac AI Monitoring And Diagnostics Market Growth Rate Analysis
  • 5.4. Global Cardiac AI Monitoring And Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiac AI Monitoring And Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiac AI Monitoring And Diagnostics Total Addressable Market (TAM)

6. Cardiac AI Monitoring And Diagnostics Market Segmentation

  • 6.1. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Diagnostics
  • Cardiac Monitoring
  • 6.2. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Hardware
  • 6.3. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ischemic Heart Diseases Or Coronary Artery Disease (CAD)
  • Cardiac Arrhythmias
  • Ischemic Stroke
  • Other Applications
  • 6.4. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Other End Users
  • 6.5. Global Cardiac AI Monitoring And Diagnostics Market, Sub-Segmentation Of Cardiac Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • ECG Analysis
  • Echocardiography Analysis
  • Cardiac Imaging
  • Biomarker Analysis
  • 6.6. Global Cardiac AI Monitoring And Diagnostics Market, Sub-Segmentation Of Cardiac Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wearable Cardiac Monitors
  • Remote Patient Monitoring Systems
  • Implantable Cardiac Devices
  • Continuous ECG Monitoring Systems

7. Cardiac AI Monitoring And Diagnostics Market Regional And Country Analysis

  • 7.1. Global Cardiac AI Monitoring And Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiac AI Monitoring And Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market

  • 8.1. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac AI Monitoring And Diagnostics Market

  • 9.1. China Cardiac AI Monitoring And Diagnostics Market Overview
  • 9.2. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac AI Monitoring And Diagnostics Market

  • 10.1. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac AI Monitoring And Diagnostics Market

  • 11.1. Japan Cardiac AI Monitoring And Diagnostics Market Overview
  • 11.2. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac AI Monitoring And Diagnostics Market

  • 12.1. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac AI Monitoring And Diagnostics Market

  • 13.1. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac AI Monitoring And Diagnostics Market

  • 14.1. South Korea Cardiac AI Monitoring And Diagnostics Market Overview
  • 14.2. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac AI Monitoring And Diagnostics Market

  • 15.1. Western Europe Cardiac AI Monitoring And Diagnostics Market Overview
  • 15.2. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac AI Monitoring And Diagnostics Market

  • 16.1. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac AI Monitoring And Diagnostics Market

  • 17.1. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac AI Monitoring And Diagnostics Market

  • 18.1. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac AI Monitoring And Diagnostics Market

  • 19.1. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac AI Monitoring And Diagnostics Market

  • 20.1. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac AI Monitoring And Diagnostics Market

  • 21.1. Eastern Europe Cardiac AI Monitoring And Diagnostics Market Overview
  • 21.2. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac AI Monitoring And Diagnostics Market

  • 22.1. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac AI Monitoring And Diagnostics Market

  • 23.1. North America Cardiac AI Monitoring And Diagnostics Market Overview
  • 23.2. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac AI Monitoring And Diagnostics Market

  • 24.1. USA Cardiac AI Monitoring And Diagnostics Market Overview
  • 24.2. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac AI Monitoring And Diagnostics Market

  • 25.1. Canada Cardiac AI Monitoring And Diagnostics Market Overview
  • 25.2. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac AI Monitoring And Diagnostics Market

  • 26.1. South America Cardiac AI Monitoring And Diagnostics Market Overview
  • 26.2. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac AI Monitoring And Diagnostics Market

  • 27.1. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac AI Monitoring And Diagnostics Market

  • 28.1. Middle East Cardiac AI Monitoring And Diagnostics Market Overview
  • 28.2. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac AI Monitoring And Diagnostics Market

  • 29.1. Africa Cardiac AI Monitoring And Diagnostics Market Overview
  • 29.2. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac AI Monitoring And Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac AI Monitoring And Diagnostics Market Competitive Landscape
  • 30.2. Cardiac AI Monitoring And Diagnostics Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac AI Monitoring And Diagnostics Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. ZOLL Medical Corporation
  • 31.3. Canon Medical Systems Corporation
  • 31.4. Biotronik SE & Co. KG
  • 31.5. iRhythm Technologies Inc.
  • 31.6. Tempus Labs Inc.
  • 31.7. Viz.ai Inc.
  • 31.8. HeartFlow Inc.
  • 31.9. Aidoc
  • 31.10. Eko Devices Inc.
  • 31.11. CardioFocus Inc.
  • 31.12. Circle Cardiovascular Imaging Inc.
  • 31.13. Ultromics Limited.
  • 31.14. Cathworks
  • 31.15. Medicalgorithmics S.A.

32. Global Cardiac AI Monitoring And Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac AI Monitoring And Diagnostics Market

34. Recent Developments In The Cardiac AI Monitoring And Diagnostics Market

35. Cardiac AI Monitoring And Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiac AI Monitoring And Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiac AI Monitoring And Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiac AI Monitoring And Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer